Skip to main content

Advertisement

Log in

Can a CT-based nomogram predict recurrence in resectable pancreatic body and tail adenocarcinoma?

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

The Original Article was published on 25 August 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395(10242):2008–2020. https://doi.org/10.1016/S0140-6736(20)30974-0

    Article  CAS  PubMed  Google Scholar 

  2. Allen PJ, Kuk D, Castillo CF et al (2017) Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients with Pancreatic Adenocarcinoma. Ann Surg. 265(1):185–191. https://doi.org/10.1097/SLA.0000000000001763

    Article  PubMed  Google Scholar 

  3. Tomasello G, Ghidini M, Costanzo A et al (2019) Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies. J Gastrointest Oncol 10(2):259–269. https://doi.org/10.21037/jgo.2018.12.08

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cannella R, Santinha J, Bèaufrere A et al (2023) Performances and variability of CT radiomics for the prediction of microvascular invasion and survival in patients with HCC: a matter of chance or standardisation? Eur Radiol. https://doi.org/10.1007/s00330-023-09852-1

  5. Shi H, Chen Z, Dong S et al (2022) A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study. BMC Gastroenterol 22(1):279. https://doi.org/10.1186/s12876-022-02362-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Li C, Ren Z, Han D et al (2020) A prognostic nomogram for pancreatic ductal adenocarcinoma patients’ all-cause survival in a Surveillance, Epidemiology, and End Results analysis. Transl Cancer Res 9(5):3586–3599. https://doi.org/10.21037/tcr-19-2962

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kim DW, Lee SS, Kim SO et al (2020) Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score. Radiology 296(3):541–551. https://doi.org/10.1148/radiol.2020200281

    Article  PubMed  Google Scholar 

  8. Xie T, Xie X, Liu W, Chen L, Liu K, Zhou Z (2023) Prediction of postoperative recurrence in resectable pancreatic body/tail adenocarcinoma: a novel risk stratification approach using a CT-based nomogram. Eur Radiol. https://doi.org/10.1007/s00330-023-10047-x

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hong SB, Lee SS, Kim JH et al (2018) Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria. Radiology 289(3):710–718. https://doi.org/10.1148/radiol.2018180628

    Article  PubMed  Google Scholar 

  10. Arrington AK, Hsu CH, Schaefer KL, O’Grady CL, Khreiss M, Riall TS (2021) Survival after Margin-Positive Resection in the Era of Modern Chemotherapy for Pancreatic Cancer: Do Patients Still Benefit? J Am Coll Surg 233(1):100–109. https://doi.org/10.1016/j.jamcollsurg.2021.02.020

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The author thanks Dr. Marco Dioguardi Burgio.

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giorgia Porrello.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Giorgia Porrello.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was not required.

Ethical approval

Institutional Review Board approval was not required.

Study subjects or cohorts overlap

None

Methodology

• Commentary

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s00330-023-10047-x.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Porrello, G. Can a CT-based nomogram predict recurrence in resectable pancreatic body and tail adenocarcinoma?. Eur Radiol 33, 7779–7781 (2023). https://doi.org/10.1007/s00330-023-10193-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-10193-2

Navigation